| 注册
首页|期刊导航|中国药物经济学|家庭药师服务模式管理老年高血压患者的药物经济学评价

家庭药师服务模式管理老年高血压患者的药物经济学评价

高艳玲 周敏华 区惠燕

中国药物经济学2024,Vol.19Issue(4):24-28,5.
中国药物经济学2024,Vol.19Issue(4):24-28,5.DOI:10.12010/j.issn.1673-5846.2024.04.004

家庭药师服务模式管理老年高血压患者的药物经济学评价

Pharmacoeconomic Evaluation of Family Pharmacist Service Model in the Management of Elderly Patients with Hypertension

高艳玲 1周敏华 1区惠燕2

作者信息

  • 1. 广东省中西医结合医院药学部,广东佛山 528200
  • 2. 佛山市南海区桂城街道社区卫生服务中心,广东佛山 528200
  • 折叠

摘要

Abstract

Objective To evaluate the economic value of family pharmacist service for elderly patients with hypertension.Methods A total of 200 elderly hypertensive patients in Guicheng community,Nanhai District,Foshan City were selected as the study objects and randomly divided into control group and observation group,with 100 cases in each group.In the control group,the doctors made and adjusted the treatment plan,and carried out the necessary diagnosis and treatment intervention,the observation group received family pharmacist service intervention on the basis of the control group.All patients were followed up for 12 months.The health data and EQ-VAS scores were collected by using the modified European 5-Dimension Health Scale before intervention and at 6-month and 12-month follow-up,the quality adjusted life years(QALYs)were calculated as the utility index in combination with the China EQ-5D-5L utility score system;the cost of all interventions during the study is used as a cost indicator,cost-utility analysis method was used for pharmacoeconomic analysis.Results Compared with the control group,the direct medical cost,indirect cost and total cost of the observation group were lower,but the difference was not significant(P>0.05);there were 14 cases and 6 cases in the control group and the observation group hospitalization due to cardiovascular and cerebrovascular events;at 12 months follow-up,the utility value and VAS score of the observation group were significantly higher than those of the control group(P<0.05);the utility value and VAS score of the observation group were significantly higher than those before intervention(P<0.05),while no significant change was found in the control group(P>0.05);compared with the control group,the cost of each additional QALYs in the observation group decreased by 31 592.77 yuan.Conclusion Pharmacist-led home pharmaceutical care model has clear economic benefits for chronic disease management of elderly patients with hypertension,reducing the cost of treatment and improving their quality of life,which is worth promoting.

关键词

家庭药师/老年高血压/药物经济学评价

Key words

Family pharmacist/Elderly hypertension/Pharmacoeconomic evaluation

分类

医药卫生

引用本文复制引用

高艳玲,周敏华,区惠燕..家庭药师服务模式管理老年高血压患者的药物经济学评价[J].中国药物经济学,2024,19(4):24-28,5.

基金项目

佛山市卫生健康局医学科研课题(20210338) (20210338)

佛山市"十四五"中医重点专科(ZDZKJS45) (ZDZKJS45)

佛山市"十四五"高水平医学重点专科(FSGSP145088) (FSGSP145088)

佛山市南海区"十四五"重点专科(南卫健[2021]211号) (南卫健[2021]211号)

佛山市中医药临床科技创新基地(佛卫函[2022]35号) (佛卫函[2022]35号)

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文